Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Identification of four novel human genes amplified and overexpressed in breast carcinoma and localized to the q11-q21.3 region of chromosome 17.

Tomasetto C, Régnier C, Moog-Lutz C, Mattei MG, Chenard MP, Lidereau R, Basset P, Rio MC.

Genomics. 1995 Aug 10;28(3):367-76.

PMID:
7490069
2.

Two distinct amplified regions at 17q11-q21 involved in human primary breast cancer.

Bièche I, Tomasetto C, Régnier CH, Moog-Lutz C, Rio MC, Lidereau R.

Cancer Res. 1996 Sep 1;56(17):3886-90.

3.

Cloning of BCAS3 (17q23) and BCAS4 (20q13) genes that undergo amplification, overexpression, and fusion in breast cancer.

Bärlund M, Monni O, Weaver JD, Kauraniemi P, Sauter G, Heiskanen M, Kallioniemi OP, Kallioniemi A.

Genes Chromosomes Cancer. 2002 Dec;35(4):311-7.

PMID:
12378525
4.

Amplification units and translocation at chromosome 17q and c-erbB-2 overexpression in the pathogenesis of breast cancer.

Coene ED, Schelfhout V, Winkler RA, Schelfhout AM, Van Roy N, Grooteclaes M, Speleman F, De Potter CR.

Virchows Arch. 1997 May;430(5):365-72.

PMID:
9174626
5.
6.
7.

Metastatic Lymph Node 51, a novel nucleo-cytoplasmic protein overexpressed in breast cancer.

Degot S, Régnier CH, Wendling C, Chenard MP, Rio MC, Tomasetto C.

Oncogene. 2002 Jun 27;21(28):4422-34.

8.

22 genes from chromosome 17q21: cloning, sequencing, and characterization of mutations in breast cancer families and tumors.

Friedman LS, Ostermeyer EA, Lynch ED, Welcsh P, Szabo CI, Meza JE, Anderson LA, Dowd P, Lee MK, Rowell SE, et al.

Genomics. 1995 Jan 1;25(1):256-63.

PMID:
7774926
9.

Identification of a novel gene, DAM1, amplified at chromosome 1p13.3-21 region in human breast cancer cell lines.

Nagasaki K, Maass N, Manabe T, Hanzawa H, Tsukada T, Kikuchi K, Yamaguchi K.

Cancer Lett. 1999 Jun 1;140(1-2):219-26.

PMID:
10403562
10.

The human homologue for the Caenorhabditis elegans cul-4 gene is amplified and overexpressed in primary breast cancers.

Chen LC, Manjeshwar S, Lu Y, Moore D, Ljung BM, Kuo WL, Dairkee SH, Wernick M, Collins C, Smith HS.

Cancer Res. 1998 Aug 15;58(16):3677-83.

11.

New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays.

Kauraniemi P, Bärlund M, Monni O, Kallioniemi A.

Cancer Res. 2001 Nov 15;61(22):8235-40.

12.

A screening method to identify genes commonly overexpressed in carcinomas and the identification of a novel complementary DNA sequence.

Byrne JA, Tomasetto C, Garnier JM, Rouyer N, Mattei MG, Bellocq JP, Rio MC, Basset P.

Cancer Res. 1995 Jul 1;55(13):2896-903.

13.

Frequent co-amplification of two different regions on 17q in aneuploid breast carcinomas.

Latham C, Zhang A, Nalbanti A, Månér S, Zickert P, Blegen H, Zetterberg A.

Cancer Genet Cytogenet. 2001 May;127(1):16-23.

PMID:
11408059
14.
15.

Concomitant gastrin and ERBB2 gene amplifications at 17q12-q21 in the intestinal type of gastric cancer.

Vidgren V, Varis A, Kokkola A, Monni O, Puolakkainen P, Nordling S, Forozan F, Kallioniemi A, Vakkari ML, Kivilaakso E, Knuutila S.

Genes Chromosomes Cancer. 1999 Jan;24(1):24-9.

PMID:
9892105
16.

Localization of the VHR phosphatase gene and its analysis as a candidate for BRCA1.

Kamb A, Futreal PA, Rosenthal J, Cochran C, Harshman KD, Liu Q, Phelps RS, Tavtigian SV, Tran T, Hussey C, et al.

Genomics. 1994 Sep 1;23(1):163-7.

PMID:
7829067
19.

Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines.

Arriola E, Marchio C, Tan DS, Drury SC, Lambros MB, Natrajan R, Rodriguez-Pinilla SM, Mackay A, Tamber N, Fenwick K, Jones C, Dowsett M, Ashworth A, Reis-Filho JS.

Lab Invest. 2008 May;88(5):491-503. doi: 10.1038/labinvest.2008.19. Epub 2008 Mar 10.

20.

Identification of differentially expressed genes associated with HER-2/neu overexpression in human breast cancer cells.

Oh JJ, Grosshans DR, Wong SG, Slamon DJ.

Nucleic Acids Res. 1999 Oct 15;27(20):4008-17.

Supplemental Content

Support Center